Development and validation of risk models to predict chronic kidney disease among people living with HIV: protocol for a systematic review

Author:

Odubela Oluwatosin OlaseniORCID,Odunukwe Nkiruka,Peer Nasheeta,Musa Adesola Z,Salako Babatunde L,Kengne A P

Abstract

IntroductionChronic kidney disease (CKD) is estimated to affect about 9.1% of the global population with a substantially increased risk of the condition (6.8%–17.2%) among people living with HIV (PLWH). This increased risk is attributed to HIV infection itself, antiretroviral therapy, coexisting viral infections, non-infectious comorbidities and traditional risk factors for CKD. Predictive models have been employed in the estimation of prevalent and incident CKD risk in both PLWH and the general population. A predictive model showing an individual’s risk of prevalent and/or progression to kidney failure is useful for initiating timely interventions that prevent further worsening of kidney function. This study will systematically review published prediction models developed and/or validated for prevalent and incident CKD in PLWH, describe their characteristics, compare performance and assess methodological quality and applicability.Methods and analysisStudies with predictive models of interest will be identified by searching MEDLINE, Web of Science, Cumulative Index to Nursing and Allied Health Literature, Cochrane library and Scopus from inception to May 2022. Title and abstract screening, full-text review and data extraction will be completed independently by two reviewers. Using appropriate tools designed for predictive modelling investigations, the included papers will be rigorously assessed for bias and applicability. Extracted data will be presented in tables, so that published prediction models can be compared qualitatively. Quantitative data on the predictive performance of these models will be synthesised with meta-analyses if appropriate.Ethics and disseminationThe findings of the review will be disseminated in peer-reviewed journals and seminar presentations. Ethical approval is not required as this is a protocol for a systematic review.PROSPERO registration numberCRD42021279694.

Funder

European Union

Publisher

BMJ

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3